Exane Derivatives’s Sprint Corporation S Stock Holding History

Exane Derivatives’s Portfolio S Stock Details S Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1	Closed	-$7	–	711
2019 Q2	$7	Hold	1	–	–	﹤0.01%	663
2019 Q1	$6	Sell	1 -493	-100%	-$3.05K	﹤0.01%	629
2018 Q4	$2.87K	Hold	494	–	–	﹤0.01%	511
2018 Q3	$3.25K	Sell	494 -15,506	-97%	-$92.1K	﹤0.01%	473
2018 Q2	$86.5K	Buy	+16,000	New	+$86.5K	0.01%	353
2017 Q1	–	Sell	-1	Closed	-$8	–	702
2016 Q4	$8	Hold	1	–	–	﹤0.01%	637
2016 Q3	$7	Hold	1	–	–	﹤0.01%	618
2016 Q2	$5	Hold	1	–	–	﹤0.01%	544
2016 Q1	$3	Hold	1	–	–	﹤0.01%	585
2015 Q4	$4	Hold	1	–	–	﹤0.01%	495
2015 Q3	$4	Hold	1	–	–	﹤0.01%	527
2015 Q2	$5	Hold	1	–	–	﹤0.01%	520
2015 Q1	$5	Sell	1 -55,337	-100%	-$261K	﹤0.01%	516
2014 Q4	$230K	Buy	+55,338	New	+$285K	0.03%	196

Other funds holding S

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Exane Derivatives's S Position: Q3 2019 in Review

Exane Derivatives sold out of Sprint Corporation (S) in Q3 2019, closing a stake of 1 share — an estimated $7 sold.

Exane Derivatives first reported a position in S in Q4 2014 and held it in 14 quarters. The position peaked at $230K in Q4 2014. 363 funds tracked by Wall St. Rank hold S as of Q3 2019.

Exane Derivatives reported no remaining Sprint Corporation position as of Q3 2019 after selling out during the quarter.
Exane Derivatives sold 1 Sprint Corporation share in Q3 2019, an estimated $7.
Exane Derivatives first reported a position in Sprint Corporation in Q4 2014 and held it in 14 quarters.
Exane Derivatives's Sprint Corporation position peaked at $230K in Q4 2014.
363 funds tracked by Wall St. Rank held Sprint Corporation as of Q3 2019.

Based on Exane Derivatives's 13F filing for Q3 2019, filed 15 Oct 2019.